Skip to main content
SpringerLink
Log in

Factor VIII comparative study sparks PRAC review

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. EMA. Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-7 March 2013. Internet Document : 8 Mar 2013. Available from: URL: http://www.ema.europa.eu.

  2. Gouw SC, et al. Factor VIII products and inhibitor development in severe hemophilia A. New England Journal of Medicine 368: 231-9, No. 3, 17 Jan 2013. Available from: URL: http://dx.doi.org/10.1056/NEJMoa1208024.

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Factor VIII comparative study sparks PRAC review. Reactions Weekly 1444, 2 (2013). https://doi.org/10.1007/s40278-013-2014-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-013-2014-4

Search

Navigation